Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Psoriatrax is a specialty healthcare company focused on the development and distribution of high-potency over-the-counter treatments for chronic dermatological conditions. The company's flagship product is a 5% coal tar solution, which is marketed as a shampoo and topical treatment for individuals suffering from psoriasis and seborrheic dermatitis. By utilizing the maximum allowable concentration of coal tar for non-prescription use, Psoriatrax aims to provide clinical-strength relief from symptoms such as scaling, itching, and inflammation. The company primarily operates through a direct-to-consumer model, selling its products via its official website and major e-commerce platforms. Its offerings serve as an accessible alternative for patients seeking effective management of moderate to severe skin conditions without a prescription.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Psoriatrax.